Skip to main content
. 2012 Oct 31;304(2):C180–C193. doi: 10.1152/ajpcell.00101.2012

Table 3.

Optimized parameter values

Optimized Parameter Value withWidth Of 95% Confidence Interval Indicated Between Parentheses (%)
Parameter Unit Description Initial Condition Model conf. i Model conf. ii Model conf. iii
kATP Hydr (0 Hz) s−1 ATPase rate constant 0 Hz 0.001a 0.0020 (±3.8%) 0.0020 (±5.1%) 0.0017 (±2.0%)
kATP_Hydr (5 Hz) s−1 ATPase rate constant 5 Hz 0.01a 0.084 (±6.4%) 0.091 (±6.8%) 0.068 (±3.1%)
kATP_Hydr (10 Hz) s−1 ATPase rate constant 10 Hz 0.01a 0.072 (±5.9%) 0.077 (±6.4%) 0.056 (±3.1%)
kATP_Hydr (40 Hz) s−1 ATPase rate constant 40 Hz 0.01a 0.060 (±5.3%) 0.065 (±6.0%) 0.049 (±2.8%)
kATP_Hydr (80 Hz) s−1 ATPase rate constant 80 Hz 0.01a 0.047 (±9.8%) 0.050 (±10.2%) 0.041 (±3.9%)
BuffCapFixed M Fixed buffer cellular proton buffer capacity 0.0142b 0.068 (±8.6%) 0.073 (±10.8%) 0.050 (±5.5%)
VmaxPFK mM/s Vmax PFK 0.93b 8.76 (±26.0%) 10.43 (±43.8%) 10.25 (±11.9%)
KAMP mM PFK deinhibition constant AMP 0.002c 0.0017 (±29.1%) 0.014 (±5.2%) 0.046 (±23.3%)
KADP mM PFK deinhibition constant ADP 0.030c 0.31 (±49.3%) 0.16 (26.6±%) 0.24 (±7.2%)
kdeinhib_Act unitless PFK deinhibition constant activated PFK 1c 8.72 * 106 (±2.45 * 105%)
KAMPact mM PFK deinhibition constant AMP activated PFK 0.002c 2.23 * 10−5 (±6.0%)
KADPact mM PFK deinhibition constant ADP activated PFK 0.030c 0.020 (±28.3%)
kon μM−2/s PFK, calcium-calmodulin binding constant 1 * 104–1 * 109 1.26 * 106 (±2.00 * 103%) 6.08 * 105 (±19.3%)
koff s−1 PFK, calcium-calmodulin binding constant 1 * 101–1 * 104 4.75 * 103 (±23.3%) 106 (±13.3%)
kATP_Hydr (1 Hz) s−1 ATPase rate constant 5 Hz 0.005a,d 0.036 (5.0%) 0.038 (15.6%) 0.032 (5.0%)
kATP_Hydr (40 Hz, 20 pulses) s−1 ATPase rate constant 40 Hz 20 pulses 0.02a,d 0.050 (20.0%) 0.042 (35.3%) 0.072 (11.6%)

PFK, phosphofructokinase; conf., configuration.

a

Estimated from initial PCr breakdown rate;

b

values used as initial condition in Ref. 55;

c

values obtained from Ref. 10;

d

estimated for validation experiments (Fig. 5).